Despite the ongoing opioid epidemic, insurers are restricting access to treatment alternatives that have a lower risk of addiction. Their reason: it’s cheaper. Patients must now make a choice between high out-of-pocket-costs or high-risk treatment. Read more, courtesy of The New York Times.